MktsMarkets

Mirum Pharmaceuticals, Inc.
NASDAQ: MIRMKey statistics
MIRM News
Stories mentioning MIRM from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 159,882 | 148,932 | 133,010 | 127,785 | 111,585 | 99,414 | 90,377 | 77,875 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 96,330 | 74,128 | 61,910 | 63,286 | 57,706 | 56,830 | 50,545 | 49,208 |
| Total Operating Expenses | 949,347 | 153,499 | 130,407 | 132,774 | 126,768 | 123,636 | 103,061 | 102,107 |
| Operating Income (Loss) | (789,465) | (4,567) | 2,603 | (4,989) | (15,183) | (24,222) | (12,684) | (24,232) |
| Interest Income | 3,401 | 3,420 | 3,251 | 3,033 | 3,023 | 3,204 | 3,469 | 3,486 |
| Interest Expense | ||||||||
| Other Expense | 0.00 | (218.00) | 395.00 | 86.00 | 2,108 | 231.00 | (1,087) | 312.00 |
| Pretax Income | (789,680) | (4,963) | 2,643 | (5,459) | (13,648) | (24,366) | (13,888) | (24,003) |
| Tax Provision | 475.00 | 767.00 | (262.00) | 402.00 | 1,029 | (576.00) | 347.00 | 635.00 |
| Net Income (Loss) | (790,155) | (5,730) | 2,905 | (5,861) | (14,677) | (23,790) | (14,235) | (24,638) |
| Earnings Per Share (Basic) | (13.43) | (0.11) | 0.06 | (0.12) | (0.30) | (0.50) | (0.30) | (0.52) |
| Earnings Per Share (Diluted) | (13.43) | (0.11) | 0.05 | (0.12) | (0.30) | (0.50) | (0.30) | (0.52) |
| Weighted Average Shares Outstanding (Basic) | 58,851 | 50,198 | 50,639 | 49,727 | 48,889 | 47,523 | 47,783 | 47,235 |
| Weighted Average Shares Outstanding (Diluted) | 58,851 | 50,198 | 56,994 | 49,727 | 48,889 | 47,523 | 47,783 | 47,235 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MIRM
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is a stock listed on the Nasdaq Stock Market under the ticker symbol MIRM. It last traded at $92.49 (Nov 18, 2026, 4:00 PM ET), up 0.6% on the day. That gives Mirum Pharmaceuticals a market capitalisation of $6.0B.
Over the past 52 weeks MIRM has traded between $63.23 and $130.00.
Revenue for the quarter ended Mar 31, 2026 was $159.9M; a net loss of $790.2M. Revenue was up 43.3% from $111.6M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $159.9M | -$790.2M | -494.2% |
| Dec 31, 2025 | $148.9M | -$5.7M | -3.8% |
| Sep 30, 2025 | $133.0M | $2.9M | 2.2% |
| Jun 30, 2025 | $127.8M | -$5.9M | -4.6% |
From Mirum Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…